0R15 8520.0 0.0% 0R1E 8203.0 0.0% 0M69 21090.0 67.5139% 0R2V 226.02 9878.8079% 0QYR None None% 0QYP 412.97 -2.8306% 0RUK 2652.0 -9.2402% 0RYA 1554.0 -0.7029% 0RIH 174.55 -1.3563% 0RIH 165.15 -5.3853% 0R1O 198.5 9800.2494% 0R1O None None% 0QFP None None% 0M2Z 267.777 -0.1763% 0VSO 32.05 -9.9846% 0R1I None None% 0QZI 559.0 0.7207% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 165.7358 2.7149%

mid-cap

Technical Analysis Report- Should You Consider this Health Care Stock - INDV

Jun 05, 2023 | Team Kalkine
Technical Analysis Report- Should You Consider this Health Care Stock - INDV

Company Overview: Indivior PLC (LSE: INDV) is an FTSE 250 Index listed North Chesterfield, USA-headquartered speciality pharmaceutical company focusing on opioid addiction treatment drugs. The report covers the Price Action, Technical Indicators Analysis along with the Target Levels, Stop Loss Level, and Recommendation on this stock.

As per our previous report on INDV as on May 02, 2023, a ‘Speculative Buy’ recommendation was given on the stock at GBX 1465.00 for a period of 2-4 weeks and noted below are the details of the recommendation summary provided in the previous report:

Recommendation Summary as on May 02, 2023

Technical Analysis:

INDV’s prices are sustaining around an upward-sloping trend line for the past couple of sessions and continuously taking support of the same trend line, indicating the possibility of an upside movement hereon. The leading indicator RSI (14-period) is above the midpoint with a rating of 67.24, and the 21-period and 50-period SMAs are below the current market price (CMP), further supporting a positive bias.

Considering the recent price action and technical indicators analysis, the stock seems in the positive territory from the technical analysis standpoint; hence a ‘Hold’ rating is recommended on the stock at the current market price of GBX 1605 as on June 05, 2023 at 11:13 AM GMT+1 for a period of 1-2 weeks. The summary of Target Levels, Stop Loss and Trail Stop Loss for INDV is provided below: 

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is June 05, 2023 at 11:13 AM GMT+1. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Technical Indicators Defined: -

Stop-loss: In general, it is a level to protect further losses in case of any unfavourable movement in the stock prices.

A trailing stop-loss is a modification of stop-loss in case of favourable movement in the price to protect the gains. Individuals can Trail the Stop-Loss as per the aforementioned levels if the stock price achieves more than 50% of the Target 1. Individuals should consider exiting from the position as per the Trailing Stop-Loss level if the price starts moving downwards after achieving more than 50% of the Target 1.


Disclaimer

References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.

This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.

Kalkine Media Limited, an affiliate of Kalkine Limited, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions